Company intelligence / Profile preview
Sagent Pharmaceuticals
Schaumburg, Illinois, USA
- Ownership
- Private
- Employees
- ~250
- Development stage
- Commercial
01
Overview
Sagent has a broad commercial portfolio of over fifty injectable products across multiple therapeutic areas in the U.S. market. The company focuses on hospital and acute-care settings with an emphasis on safety through innovative packaging.[1][2][7] No proprietary clinical-stage assets; all marketed as generics or via partnerships.
- Therapeutic areas
- OtherOncologyInfectious Diseases
- Modalities
- Small molecules (injectable generics)Biologics (limited; focus on injectables)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Strides Arcolab—joint development/manufacturing partnership for U.S. injectable market [6]
Beyond the preview
Go deeper on Sagent Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sagent Pharmaceuticals.